Your browser doesn't support javascript.
loading
Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.
Popat, Rakesh; Warcel, Dana; O'Nions, Jenny; Cowley, Anna; Smith, Sasha; Tucker, William R; Yong, Kwee; Esposti, Simona Degli.
Afiliação
  • Popat R; National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust rakesh.popat@ucl.ac.uk.
  • Warcel D; National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust.
  • O'Nions J; National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust.
  • Cowley A; National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust.
  • Smith S; National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust.
  • Tucker WR; National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK.
  • Yong K; National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust.
  • Esposti SD; National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK.
Haematologica ; 105(5): e261-e263, 2020 05.
Article em En | MEDLINE | ID: mdl-32107339

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article